Exelixis
EXEL
#1888
Rank
A$15.39 B
Marketcap
A$60.60
Share price
-1.75%
Change (1 day)
-1.37%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company